Game changers in pain management

Periarticular injections

Research output: Contribution to journalArticle

Abstract

Periarticular injection (PAI) of anesthetics is an important and effective component of multimodal pain therapy in total knee arthroplasty, which as been extensively reported and supported in the literature. The existing data supports that liposomal bupivacaine is an effective PAI that can be used to provide comparable pain relief to that achieved by regional blocks. However, liposomal bupivacaine has not been shown to provide superior pain relief when compared to traditional ropivacaine or bupivacaine PAI's in multimodal pain protocols after TKA. Further, liposomal bupivacaine is prohibitively priced at approximately six times that of ropivacaine-based PAI cocktails. Therefore, the “game changer” is the implementation of periarticular injections as an essential component of multimodal pain control programs and NOT liposomal bupivacaine as the ingredient. Finally, it is likely that preoperative education focused on expectation management combined with a multimodal pain protocol are the most effective strategies for controlling pain and optimizing outcomes after TKA.

Original languageEnglish (US)
Pages (from-to)50-52
Number of pages3
JournalSeminars in Arthroplasty
Volume28
Issue number2
DOIs
StatePublished - Jun 1 2017

Fingerprint

Pain Management
Bupivacaine
Pain
Injections
Knee Replacement Arthroplasties
Anesthetics
Education

Keywords

  • Bupivacaine
  • Liposomal bupivacaine
  • Pain control
  • Periarticular injection
  • Total knee arthroplasty

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Game changers in pain management : Periarticular injections. / Meneghini, R.

In: Seminars in Arthroplasty, Vol. 28, No. 2, 01.06.2017, p. 50-52.

Research output: Contribution to journalArticle

@article{ef399c3165d44ac5a8d5cf069ad86083,
title = "Game changers in pain management: Periarticular injections",
abstract = "Periarticular injection (PAI) of anesthetics is an important and effective component of multimodal pain therapy in total knee arthroplasty, which as been extensively reported and supported in the literature. The existing data supports that liposomal bupivacaine is an effective PAI that can be used to provide comparable pain relief to that achieved by regional blocks. However, liposomal bupivacaine has not been shown to provide superior pain relief when compared to traditional ropivacaine or bupivacaine PAI's in multimodal pain protocols after TKA. Further, liposomal bupivacaine is prohibitively priced at approximately six times that of ropivacaine-based PAI cocktails. Therefore, the “game changer” is the implementation of periarticular injections as an essential component of multimodal pain control programs and NOT liposomal bupivacaine as the ingredient. Finally, it is likely that preoperative education focused on expectation management combined with a multimodal pain protocol are the most effective strategies for controlling pain and optimizing outcomes after TKA.",
keywords = "Bupivacaine, Liposomal bupivacaine, Pain control, Periarticular injection, Total knee arthroplasty",
author = "R. Meneghini",
year = "2017",
month = "6",
day = "1",
doi = "10.1053/j.sart.2017.07.007",
language = "English (US)",
volume = "28",
pages = "50--52",
journal = "Seminars in Arthroplasty",
issn = "1045-4527",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Game changers in pain management

T2 - Periarticular injections

AU - Meneghini, R.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Periarticular injection (PAI) of anesthetics is an important and effective component of multimodal pain therapy in total knee arthroplasty, which as been extensively reported and supported in the literature. The existing data supports that liposomal bupivacaine is an effective PAI that can be used to provide comparable pain relief to that achieved by regional blocks. However, liposomal bupivacaine has not been shown to provide superior pain relief when compared to traditional ropivacaine or bupivacaine PAI's in multimodal pain protocols after TKA. Further, liposomal bupivacaine is prohibitively priced at approximately six times that of ropivacaine-based PAI cocktails. Therefore, the “game changer” is the implementation of periarticular injections as an essential component of multimodal pain control programs and NOT liposomal bupivacaine as the ingredient. Finally, it is likely that preoperative education focused on expectation management combined with a multimodal pain protocol are the most effective strategies for controlling pain and optimizing outcomes after TKA.

AB - Periarticular injection (PAI) of anesthetics is an important and effective component of multimodal pain therapy in total knee arthroplasty, which as been extensively reported and supported in the literature. The existing data supports that liposomal bupivacaine is an effective PAI that can be used to provide comparable pain relief to that achieved by regional blocks. However, liposomal bupivacaine has not been shown to provide superior pain relief when compared to traditional ropivacaine or bupivacaine PAI's in multimodal pain protocols after TKA. Further, liposomal bupivacaine is prohibitively priced at approximately six times that of ropivacaine-based PAI cocktails. Therefore, the “game changer” is the implementation of periarticular injections as an essential component of multimodal pain control programs and NOT liposomal bupivacaine as the ingredient. Finally, it is likely that preoperative education focused on expectation management combined with a multimodal pain protocol are the most effective strategies for controlling pain and optimizing outcomes after TKA.

KW - Bupivacaine

KW - Liposomal bupivacaine

KW - Pain control

KW - Periarticular injection

KW - Total knee arthroplasty

UR - http://www.scopus.com/inward/record.url?scp=85028702960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028702960&partnerID=8YFLogxK

U2 - 10.1053/j.sart.2017.07.007

DO - 10.1053/j.sart.2017.07.007

M3 - Article

VL - 28

SP - 50

EP - 52

JO - Seminars in Arthroplasty

JF - Seminars in Arthroplasty

SN - 1045-4527

IS - 2

ER -